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Abstract
Background: The cardiovascular autonomic nervous system in obese children is one of the
main initiators of coronary heart disease and hypertension and may have a close relationship
with insulin resistance. Heart rate variability is one non-invasive method to assess the
cardiovascular autonomic system. In this method, low frequency parameters reflect
sympathovagal activity, high frequency parameters reflect vagal activity and the ratio of these
parameters reflects sympathovagal balance.
Methods: In this study, a short-term analysis of heart rate variability was conducted in
66 obese children and 40 healthy controls.
Results: While high frequency parameter values are lower in the obese group compared to the
controls (16.02 ± 12.9 nu vs. 21.45 ± 13.6 nu, p = 0.046), the low frequency/high frequency
ratio is found significantly higher (3.79 ± 2.34 vs. 2.25 ± 0.93, p < 0.001). A significant
difference was not detected for the low frequency values (p = 0.787). Insulin resistance was
found in 33 (50%) patients, dyslipidemia was found in 39 (59%) and hypertension was found
in 18 (27%). Metabolic syndrome was detected in 39% patients in the obese group.
Conclusions: We found that vagal activity was decreased in the obese group and the
autonomic nervous system balance was impaired in favor of sympathetic activity in the short-
-term heart rate analysis. (Cardiol J 2012; 19, 5: 501–506)
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Introduction
Obesity is the most prevalent seen nutritional
disorder in childhood, and it increases cardiovascular
(CV) morbidity and mortality risk through various
mechanisms [1–3]. The most common mechanisms
include insulin resistance, dyslipidemia, hyperten-
sion, metabolic syndrome (MS), diabetes, and car-
diac hypertrophy. Previous studies analyzing heart
rate variability (HRV) parameters have shown that
CV autonomic dysfunction occurs in various disor-
ders. This condition leads to obesity-related hyper-
tension, which affects the heart, kidneys and vas-
culature and coronary heart diseases [1].
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The key factor in the development of obesity,
MS, and diabetes is insulin resistance. The topics
related to insulin resistance are chronic low-grade
inflammation, CV autonomic dysfunction and sym-
pathetic hyperactivity. HRV is an indicator of cardiac
control. Previously, a lower HRV has been linked
to detrimental health changes and outcomes, such
as the development of hypertension, diabetes, and
coronary artery diseases (CAD) in individuals with
diabetes [4–6].
In this study, we investigated MS parameters
and the CV autonomic nervous system using HRV
analysis. We investigated the effects of alterations
in the autonomic nervous system and the effective-
ness of short-term HRV analysis to reveal CAD risk
in the early period in obese children.
Methods
A total of 66 children, 8–16 years of age were
enrolled in the study. These children were admit-
ted to our outpatient clinic with and obesity related
complaint or were found to be obese when they
were admitted for other complaints. During the first
assessment, a detailed medical history was ob-
tained, and a physical examination was performed.
The children who had known systemic or metabo-
lic diseases, used medications that may affect body
weight or had syndrome findings were excluded.
During the anamnesis, all subjects were questioned
about the duration of obesity and family history of
obesity, early-onset CAD, hyperlipidemia and dia-
betes. Forty healthy children, 8–16 years of age
were included in the study as a control group. Lo-
cal ethics committee approval was obtained for this
study. Families were informed about the proce-
dures, and written informed consent was obtained.
All anthropometric measurements were per-
formed by the same person with child only wearing
underclothing without socks and shoes. Height was
measured with the child standing using a standard
height measure scale fixed onto the wall with
a margin of error of 0.5 cm. Weight was measured
using a single bascule with a constant zero adjust-
ment with a margin of error of 0.1 kg. Blood pres-
sure was measured after resting using a standard
mercury manometer. The mean value of two se-
quential measurements were obtained in the sitting
position with a 10 min interval after a resting peri-
od of 10 min using a proper sized cuff for age that
covered 2/3 of the left arm. Individuals with systo-
lic and diastolic blood pressures above the 95th per-
centile for age and gender considered to be hyper-
tensive. Body mass index (BMI) was calculated by
dividing body weight [kg] by height [m2]. Patients
with a BMI above the 95th percentile for age and
gender using national definitions were classified as
obese [7].
Venous blood samples for glucose, insulin, cho-
lesterol and triglyceride levels were obtained from
all obese children after fasting for 12 h at night.
Standard enzymatic methods were used to measure
cholesterol and triglycerides levels. The serum
high-density lipoprotein (HDL) cholesterol concen-
tration was measured from the supernatant after
precipitation of very low- and low-density lipopro-
tein (LDL) cholesterol. LDL cholesterol concentra-
tion was calculated with the Friedewald formula.
The glucose concentration was analyzed enzymat-
ically, and serum insulin was measured with a mi-
croparticle enzyme immunoassay kit. The oral glu-
cose tolerance test (1.75 g/kg glucose, max 75 g)
was performed for all of the obese children. Fasting
plasma glucose ≥ 110 mg/dL was defined as impaired
fasting glucose, and ≥ 126 mg/dL was defined as
diabetes. Plasma glucose and insulin were mea-
sured at 0, 30, 60, and 120 min. A 2 h blood glucose
< 140 mg/dL was classified as normal, 140–200 mg/
/dL as impaired glucose tolerance, and ≥ 200 mg/
/dL as diabetes. Insulin resistance was calculated
using the homeostasis model assessment of insu-
lin resistance (HOMA-IR; fasting insulin mU/L ×
× fasting glucose mmol/L/22.5), and a HOMA-IR
> 3.16 was considered to represent insulin resis-
tance [2]. The diagnosis of MS was made according
to the modified criteria of the International Diabe-
tes Federation (IDF) consensus report for children
[1, 3]. The criteria were the presence of obesity
with a BMI > 90th percentile for age and sex and
the presence of at least two of the following condi-
tions: 1) fasting blood glucose >100 mg/dL, diabe-
tes mellitus, insulin resistance (the cut-off point for
our study was > 3.16) or impaired glucose toler-
ance testing, 2) hypertension, 3) hypertriglyceri-
demia (≥ 150 mg/dL), and 4) HDL cholesterol lev-
els < 40 mg/dL.
Heart rate analysis
While at rest in a sitting position and not speak-
ing or moving unless necessary in a small room,
a Holter electrocardiogram was recorded for each
subject for 20 min (Rozinn Electronics, NY, USA).
All measurements were then manually revised by
one operator (O.B.). The ectopic beats were delet-
ed and removed from the R-R sequences for HRV
analysis. We calculated the mean heart rate and fre-
quency domain indices during the short-term peri-
ods. The advantages of short-term HRV data anal-
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ysis include its simplicity. In addition, because the
data are collected in a controlled environment, they
may be more suitable for analysis. For the frequency
domain analysis, 5-min long R-R time series were
interpolated at 250 ms to obtain equidistant values.
Subsequently, a fast Fourier transformation was
applied. The spectral components of total power
(TP), very low frequency (VLF, 0.003–0.04 Hz), low
frequency (LF, 0.04–0.15 Hz) and high frequency
(HF, 0.15–0.40 Hz) in normalized units (LF nu and
HF nu, respectively) and in milliseconds squared
were used [8–13]. We used the LF to HF ratio (LF/
/HF) as an index of cardiac sympathovagal balance.
Statistical assessment
All data are shown as the means ± SD. Statis-
tical Package for the Social Sciences 11.0 (SPSS,
Inc., Chicago, IL, USA) was used for data assess-
ment using Student’s t test. P values below 0.05
were considered to be statistically significant.
Results
A total of 106 children (51.9% girls, 48.1% boys,
mean age 11.6 ± 2 years) were evaluated in this
study. The obese group had 66 children (31 boys
and 35 girls). The nonobese group had 40 children
(20 boys, 20 girls). Anthropometric measurements
for the study group are shown in Table 1.
All of the obese children’s BMI were higher
than the 95th percentile for age and sex. Hyperten-
sion was detected in 18 (27.2%) subjects in the
obese group. Arterial hypertension (systolic or
diastolic) was present in 29% of the boys and 25.7%
of the girls. The mean triglyceride level in the obese
group was 161 ± 72 mg/dL, the mean HDL choles-
terol was 46 ± 11 mg/dL and dyslipidemia was de-
tected in 39 (59%) cases. The mean triglyceride
level in the obese boys was 156 ± 73 mg/dL, and
the mean HDL cholesterol was 47 ± 13 mg/dL. The
mean triglyceride level in the obese girls was
166 ± 72 mg/dL, and the mean HDL cholesterol was
found as 45 ± 9 mg/dL. Dyslipidemia was present
in 64.5 and 54.3% of boys and girls, respectively.
None of the parameters in the obese group dif-
fered significantly between boys and girls. Insulin
resistance, measured by HOMA-IR, was not signi-
ficantly different between the sexes, (girls: 3.03 ±
± 2.09, boys: 3.57 ± 2.89, p = 0.381). In total, there
were 33 cases of insulin resistance (17 obese boys
[55%] and 16 obese girls [45%]). The distribution
of risk factors between the obese girls and boys are
shown in Figure 1.
In terms of MS diagnosis, in addition to obesi-
ty, the coexistence of insulin resistance and hyper-
tension was found in 4 patients; insulin resistance
and dyslipidemia was found in 8 patients; and final-
ly a combination of insulin resistance, hypertension
Table 1. Anthropometric measurements in the study groups.
Obese groups (n = 66) Nonobese controls (n = 40) P
Sex (male/female) 31/35 20/20
Age [year] 11.6 ± 2.05 11.6 ± 2.15 0.932
Height [cm] 150.5 ± 12.39 142.2 ± 12.23 0.001*
Weight [kg] 67.8 ± 16.89 34.7 ± 8.93 0.001*
Body mass index [kg/m2] 29.3 ± 3.65 16.6 ± 1.49 0.001*
Systolic blood pressure [mm Hg] 113 ± 12 104 ± 10 0.001*
Diastolic blood pressure [mm Hg] 73 ± 10 67 ± 7 0.001*
*Statistically significant
Insulin
resistance
Impaired
OGTT
Hypertension Increased
triglyceridemia
Decreased
HDL
Girls
Boys
0
5
10
15
20
25
30
35
Figure 1. Distribution of risk factors in obese girls and
boys; OGTT — oral glucose tolerance testing; HDL —
high-density lipoprotein cholesterol.
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and dyslipidemia was found in 14 patients. In total,
MS was found in 26 (39.4%) cases. The diagnosis
of MS according to modified IDF criteria is given in
Figure 2.
The mean heart rate was 95.33 ± 8.37 bmp in
the obese group compared to 77.53 ± 4.3 bpm in
the control group (p < 0.001). The mean VLF was
1040 ± 314 ms2 in the obese group compared to
1107 ± 454 ms2 in the control group (p = 0.419).
The mean LF was 40.68 ± 13.4 nu in the obese
group compared to 39.97 ± 12.6 nu in the control
group (p = 0.787). The mean HF was 16.02 ± 12.90 nu
in the obese group compared to 21.45 ± 13.66 nu in
the control group (p = 0.046). The mean LF/HF ra-
tio was 3.79 ± 2.34 in the obese group compared to
2.25 ± 0.93 in the control group (p < 0.001). The
HRV parameters in the study group are given in
Table 2.
At the subgroup analysis, the mean VLF, the
mean LF, the mean HF and the mean LF/HF ratio
were not different in the obese with and without MS
groups (p > 0.5). And also these parameters were
not different in the obese with and without insulin
resistance patients (p > 0.5).
Of the HRV parameters, TP, VLF, LF and HF
were higher in the obese boys compared to the girls.
LF elevation was statistically significant (p = 0.042);
however the others were not significant (p = 0.160,
p = 0.660, p = 0.404, respectively). The LF/HF
ratio was higher in the obese girls; however, this
difference was not significant (p = 0.558).
Discussion
Children who are obese in childhood are at risk
for obesity and CAD in adulthood. The frequencies
of type 2 diabetes and insulin resistance, which are
particularly severe risk factors for CAD, have be-
gun to increase dramatically among children in re-
cent years in parallel with the incidence of obesity
[3]. Insulin resistance coexists with increased sym-
pathetic nervous system activation. The association
between fasting insulin levels in hypertensive obese
individuals and sympathetic system activation in the
first and the second decades of life have been de-
tected [14].
Rabbia et al. [15] studied 50 obese children; 11–
–15 years of age to detect CV autonomic functional
changes in obese children. The mean heart rate, TP,
LF, HF and LF/HF were estimated using the HRV
method with a 24 h recording period. The high HRV
and mean heart rate, which indicate sympathetic
nervous system activity, and LF ratios indicate the
sympathovagal interaction, were increased. The HF
band, which indicates parasympathetic activity, was
decreased, and the LF/HF ratio, which indicates au-
tonomic nervous system balance, was increased in
favor of sympathetic activity in the obese group.
Based on these results, researchers have advocated
that increased cardiac activity is one of the main fac-
tors for the emergence of insulin resistance and obe-
sity-related hypertension [15].
Martini et al. [16] investigated 32 obese chil-
dren and adolescents, 11–16 years of age to detect
early CV autonomic dysfunction, and to identify the
accompanying risk factors. In the obese group, they
found that their HF values, which indicate parasym-
pathetic activity, were significantly lower in the
24 h recording period. The LF values were higher
Figure 2. Coexistence of risk factors in the obese group.
Table 2. Heart rate variability parameters in the study groups.
Obese groups (n = 66) Nonobese groups (n = 40) P
Mean heart rate [bpm] 95 ± 8.3 77 ± 4.3 0.001*
Total power [ms2] 1847 ± 893 2077 ± 1012 0.240
Very low frequency [ms2] 1040 ± 314 1107 ± 454 0.419
Low frequency [nu] 40.68 ± 13.4 39.97 ± 12.6 0.787
High frequency [nu] 16.02 ± 12.9 21.45 ± 13.6 0.046*
Low frequency/high frequency 3.79 ± 2.34 2.25 ± 0.93 0.001*
*Statistically significant
Obesity
Hypertension
Dyslipidemia
17
8
14
4 7
16
Insulin
resistance
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in the control group, although the difference was
insignificant. The LF/HF ratio was high indicating
a reduction in vagal activity. The fasting blood glucose,
fasting insulin, mean blood pressure, HOMA-IR and
triglyceride values were elevated and the HDL cho-
lesterol was low in the obese children. Research-
ers have suggested that insulin resistance facilitates
the emergence of CV diseases through increased
sympathetic autonomic activity [16].
Guizar et al. [17] compared HRV in 34 obese
male children and adolescents, 12–17 years of age
to a control group. In the obese children, they found
a low HF which indicates decreased parasympa-
thetic activity, and increased LF/HF which indicates
impaired autonomic balance. They found high insu-
lin, blood pressure, triglyceride, HOMA-IR values
and low HDL cholesterol in the obese group [17].
Additionally, Riva et al. [18] investigated HRV
in 24 obese children and found high LF/HF, and low
HF which indicates that autonomic balance is im-
paired in childhood obesity. Riva et al. [18] claimed
that increased sympathetic activity and impaired
autonomic balance are important factors that fa-
cilitate the long-term development of hypertension.
One of the significant and striking factors that
make our study unique and differentiates it from
other studies is that the recordings were meticu-
lously performed during a 20 min period. LF param-
eter values, which indicate sympathovagal activi-
ty, were higher, but the difference was insignificant.
This result represents a significant reduction in
parasympathetic activity. In conclusion, in our
study, the LF/HF was increased significantly, and
the CV autonomic system balance was impaired in
favor of sympathetic activity, which is consistent
with the literature [15–18]. Based on this result, we
may claim that cardioautonomic function may be
checked by measuring HRV through 20 min record-
ings without the need for 24 h recordings.
In our study, CV autonomic balance was im-
paired in favor of the sympathetic system in obese
children and 50% of the patients had insulin resis-
tance. In the literature, it has been stated that there
is a close relationship between obesity and insulin
resistance and the development of MS is higher
among those individuals [1, 3]. There are some dif-
ficulties concerning making comparisons because
different definitions are used in studies investigat-
ing the incidence of MS. In the Bugalosa Heart
Study, the MS incidence was 4% in white children
and 3% in black children based on fasting insulin
and insulin resistance [19, 20]. Cook et al. [21] found
that the incidence of MS was 28.7% when only the
obese group was taken into consideration. Addition-
ally, in our study, insulin resistance was detected
in 50% of patients, and MS was detected in 39.4%
patients. Insignificant HRV parameters in obese
children with and without MS and insulin resistance
suggest that there might be unknown issues about
relations obesity and autonomic nervous systems.
Conclusions
Various impairments occur in the autonomic
nervous system during the development of obesi-
ty. The balance was changed in favor of sympathetic
activity, and vagal activity was decreased and had
a significant role in obesity-related hypertension.
In addition, insulin resistance is perhaps the most
important factor that impairs sympathovagal acti-
vity, which is supported with studies.
In childhood obesity and in children with insu-
lin resistance, HRV measurement that is a nonin-
vasive and relatively cheap technique that may be
used for the early diagnosis of CV diseases, and
valuable data may be obtained with short recording
times. A population-based study with a larger sample
and a longer follow up period would better identify
the relationship between obesity and metabolic dis-
orders and CV autonomic balance, and would en-
able the use of new treatments in the early period.
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